Bone Health Protocol

MusculoskeletalStrong Evidence

supplements

Primary

Supporting

Grade A

178

Studies

Primary Stack

Core supplements with strongest evidence

Vitamin D3A

2000-4000 IU daily (adjust based on blood levels)

Enhances intestinal calcium absorption and regulates osteoblast/osteoclast balance

↑Bone turnover markers↑Fracture Risk↑Calcium Absorption↑Parathyroid Hormone

85 studies95,000 participants

Supporting Studies (2)

PMID: 29429436 - Vitamin D and fracture prevention meta-analysis (2018)PMID: 28859222 - Vitamin D supplementation guidelines (2017)

Vitamin K2 (MK-7)A

180-200mcg daily

Activates osteocalcin to direct calcium into bone matrix and prevent arterial deposition

↑Bone Mineral DensityC-Reactive Protein (CRP)↑Fracture Risk↓Weight↓Interleukin 6

12 studies1,800 participants

Supporting Studies (1)

PMID: 23525894 - Three-year vitamin K2 supplementation and bone loss (2013)

Calcium (Citrate preferred)A

500-600mg twice daily (with meals)

Provides substrate for hydroxyapatite crystal formation in bone matrix

↑Bone Mineral Density

60 studies45,000 participants

Supporting Studies (1)

PMID: 17720017 - Calcium supplementation and bone density (2007)

Supporting Stack

Additional supplements for enhanced results

MagnesiumB

300-400mg daily

Required for vitamin D activation and bone crystal formation; 60% of body magnesium is in bone

↑Bone Mineral Density↑Osteocalcin

8 studies1,200 participants

Supporting Studies (1)

PMID: 23912656 - Magnesium and bone health (2013)

Collagen PeptidesB

5-10g daily

Provides amino acids for bone organic matrix and stimulates osteoblast activity

6 studies450 participants

Supporting Studies (1)

PMID: 29337906 - Collagen peptides and bone mineral density (2018)

BoronC

3-6mg daily

Enhances vitamin D and estrogen metabolism; reduces urinary calcium excretion

Serum Calcium↑Serum Magnesium

4 studies180 participants

Silicon (Orthosilicic Acid)C

6-12mg daily

Essential for collagen cross-linking in bone matrix

3 studies120 participants

How This Protocol Works

Simple Explanation

Bone is living tissue that constantly remodels—osteoclasts break down old bone while osteoblasts build new bone. This protocol supports both the mineral and organic components of bone.

•Vitamin D3 is essential—without adequate D, you absorb only 10-15% of dietary calcium. Most people need 2000-4000 IU daily to reach optimal blood levels (40-60 ng/mL).

•Vitamin K2 works synergistically with D. It activates osteocalcin, a protein that binds calcium and incorporates it into bone. Without K2, calcium may deposit in arteries instead of bones.

•Calcium provides the raw material for bone. Citrate form is preferred—it's better absorbed and doesn't require stomach acid (important for older adults).

•Magnesium is required to convert vitamin D to its active form and is itself a component of bone mineral.

•Collagen peptides support the organic matrix that gives bone its flexibility and resistance to fracture.

•Boron and silicon are trace minerals involved in bone metabolism that many diets lack.

Expected timeline: Bone is slow to change—expect DEXA improvements over 12-24 months. Reduced fracture risk may occur sooner through improved bone quality.

Clinical Perspective

Bone remodeling involves RANK/RANKL/OPG signaling (osteoclast activation) and Wnt/β-catenin pathway (osteoblast differentiation). This protocol targets both pathways and provides essential cofactors.

•Vitamin D3 (A-grade): Binds VDR, upregulating intestinal calcium absorption (TRPV6 channels) and renal calcium reabsorption. Also modulates RANKL/OPG ratio. Target: serum 25-OH-D of 40-60 ng/mL. Meta-analysis: 800+ IU/day reduces fracture risk 14-20% (PMID: 29429436).

•Vitamin K2 MK-7 (A-grade): γ-carboxylates osteocalcin (bone) and MGP (vascular). Undercarboxylated osteocalcin is a marker of K deficiency. 3-year RCT: 180mcg MK-7 reduced bone loss and improved bone strength indices (PMID: 23525894).

•Calcium citrate (A-grade): Better absorbed than carbonate (especially with PPI use or achlorhydria). Split doses of 500-600mg optimize absorption. Take with meals to reduce kidney stone risk.

•Magnesium (B-grade): Cofactor for 25-hydroxylase and 1α-hydroxylase (vitamin D activation). 60% of body Mg is in bone. Deficiency impairs PTH secretion and induces PTH resistance.

•Collagen peptides (B-grade): Provide glycine, proline, hydroxyproline for bone matrix. Specific peptides may stimulate osteoblast differentiation via GPRC6A receptor. 12-month RCT: 5g/day increased BMD significantly (PMID: 29337906).

•Boron (C-grade): Reduces urinary calcium/magnesium excretion. May modulate estrogen receptor activity.

Biomarker monitoring: 25-OH vitamin D, PTH, serum calcium, bone-specific ALP, CTX (resorption), P1NP (formation). DEXA every 1-2 years.

Important: Ensure adequate protein intake (1-1.2g/kg) and weight-bearing exercise for optimal results.

View All Protocols